You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Liver tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intra-procedural 360-degree Display for Performing Percutaneous

Enrolling by invitation
  • Percutaneous Tumor Ablation
  • HoloLens
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 17, 2023

Liver Cancer Trial in Luzhou (FluoAB)

Recruiting
  • Liver Cancer
  • Luzhou, Sichuan, China
    The Affiliated Hospital of Southwest Medical University
May 26, 2022

Liver Tumor Trial in Warsaw (Pneumoperitoneum 14mmHg, Pneumoperitoneum 10mmHg)

Recruiting
  • Liver Tumor
  • Pneumoperitoneum 14mmHg
  • Pneumoperitoneum 10mmHg
  • Warsaw, Poland
    Department of General, Transplant and Liver Surgery, Medical Uni
Sep 23, 2023

Liver Cancer Trial in Wuhan (Autologous Tumor Infiltrating Lymphocytes)

Recruiting
  • Liver Cancer
  • Autologous Tumor Infiltrating Lymphocytes
  • Wuhan, China
    Tongji Hospital
Oct 9, 2023

Artificial Intelligence Assisted Liver Tumor Ablation Path

Not yet recruiting
  • Liver Tumor
  • Accuracy evaluation
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 3, 2021

Liver Tumor Trial in Warsaw (Laparoscopic liver resection)

Recruiting
  • Liver Tumor
  • Laparoscopic liver resection
  • Warsaw, Poland
    Department of General, Transplant and Liver Surgery, Medical Uni
Aug 24, 2022

Liver Tumor Trial in Cincinnati (RFA controlled using echo decorrelation imaging, RFA controlled using standard

Recruiting
  • Liver Tumor
  • RFA controlled using echo decorrelation imaging
  • RFA controlled using standard manufacturer-specified algorithms
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Jul 12, 2022

Relapsed Hepatoblastoma, Refractory Hepatoblastoma Trial in Cincinnati (Biospecimen collection)

Recruiting
  • Relapsed Hepatoblastoma
  • Refractory Hepatoblastoma
  • Biospecimen collection
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Sep 29, 2022

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase

Recruiting
  • Liver Transplant
  • PVHA or TACE
  • Shanghai, Shanghai, China
    The value of tumor feeding vessels deprivation combined with tyr
Nov 26, 2022

Liver Tumor, HCC, Metastasis Trial in Worldwide (HistoSonics Histotripsy)

Recruiting
  • Liver Tumor
  • +2 more
  • HistoSonics Histotripsy
  • Braunschweig, Germany
  • +5 more
Oct 13, 2022

Liver Tumor, HCC, Metastasis Trial in United States (HistoSonics Histotripsy)

Recruiting
  • Liver Tumor
  • +2 more
  • HistoSonics Histotripsy
  • Miami, Florida
  • +7 more
Jan 3, 2023

Treat Primary and Metastatic Liver Tumors

Enrolling by invitation
  • Intrahepatic Cholangiocarcinoma
  • +3 more
    • Dallas, Texas
      Methodist Dallas Medical Center
    Feb 3, 2022

    Liver Tumor Trial (Entotracheal tube size)

    Not yet recruiting
    • Liver Tumor
    • Entotracheal tube size
    • (no location specified)
    May 12, 2022

    PDO/PDO-TIL/PDOTS for Drug Screen

    Recruiting
    • Liver Cancer
    • Metastatic Liver Cancer
    • Drug screen with PDO/PDO-TIL/PDOTS
    • Shanghai, Shanghai, China
      Zhongshan Hospital, Fudan University
    Jun 13, 2023

    Perihilar Cholangiocarcinoma Trial in Padova (Liver transplantation)

    Not yet recruiting
    • Perihilar Cholangiocarcinoma
    • Liver transplantation
    • Padova, Italy
      Azienda Ospedale Università di Padova
    Nov 5, 2023

    Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)

    Recruiting
    • Hepatocellular Carcinoma
    • +6 more
    • Embolization
    • Milan, Italy
      IRCCS Ospedale San Raffaele
    Feb 3, 2023

    Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I

    Not yet recruiting
    • Posto Perative Hepatocellular Carcinoma
    • Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
    • (no location specified)
    Feb 27, 2023

    Liver Tumor Trial in Guangzhou (TACE combined with Lenvatinib)

    Recruiting
    • Liver Tumor
    • TACE combined with Lenvatinib
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 23, 2022

    Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,

    Not yet recruiting
    • Metastatic Uveal Melanoma
    • Metastatic Cutaneous Melanoma
    • Autologous Tumor Infiltrating Lymphocytes
    • +2 more
    • (no location specified)
    Oct 14, 2022

    Hepatocellular Carcinoma in Chronic Liver Disease Using

    Recruiting
    • Cirrhosis； Tumor
      • Zhuhai, Guangdong, China
        Yaqin, Zhang
      Sep 25, 2023

      Covid-19 Infection in Patients With Underlying Diseases

      Not yet recruiting
      • Chronic Liver Disease
      • +3 more
      • underling disease
      • (no location specified)
      Aug 1, 2023

      Laparoscopic Associating Liver Partition and Portal Vein

      Recruiting
      • Liver Tumor
      • Laparoscopic ALPPS
      • Chongqing, China
        Southwest Hospital
      Jan 13, 2022

      Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen

      Recruiting
      • Advanced Cholangiocarcinoma
      • +6 more
      • Biospecimen Collection
      • +3 more
      • Los Angeles, California
      • +1 more
      Mar 31, 2023

      Hepatocellular Carcinoma, Desflurane Adverse Reaction, Propofol Adverse Reaction Trial in Hangzhou (Des?urane, Propofol)

      Completed
      • Hepatocellular Carcinoma
      • +3 more
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer hospital
      Aug 15, 2022